Skip to main content
Top
Published in: Clinical & Experimental Metastasis 4/2003

01-07-2003

Triterpenoids from Glycine max decrease invasiveness and induce caspase-mediated cell death in human SNB19 glioma cells

Authors: Niranjan Yanamandra, Mark A. Berhow, Santhi Konduri, Dzung H. Dinh, Willam C. Olivero, Garth L. Nicolson, Jasti S. Rao

Published in: Clinical & Experimental Metastasis | Issue 4/2003

Login to get access
Metadata
Title
Triterpenoids from Glycine max decrease invasiveness and induce caspase-mediated cell death in human SNB19 glioma cells
Authors
Niranjan Yanamandra
Mark A. Berhow
Santhi Konduri
Dzung H. Dinh
Willam C. Olivero
Garth L. Nicolson
Jasti S. Rao
Publication date
01-07-2003
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 4/2003
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1023/A:1024043104803

Other articles of this Issue 4/2003

Clinical & Experimental Metastasis 4/2003 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine